Circadian variations of salivary melatonin levels in women of reproductive and postmenopausal age with gynoid and android obesity

Endocrine Regulations

Volumn 30, Issue 3, 1996, Pages 143-152

  Ostrowska, Z ^a   Buntner, B ^a   Banas, I ^a   Kos Kudla, B ^a   Marek, B ^a   Zwirska Korczala, K ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Android Obesity; Gynoid Obesity; Postmenopausal Age; Reproductive Age; Salivary Melatonin

Indexed keywords

EID: 0010041718     PISSN: 12100668     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. ARENDT J: Melatonin and the human circadian system. In: Melatonin - Clinical Perspectives. Oxford University Press, Oxford (Ed. A. Miles, D.R.S. Philbrick, C. Thompson), pp. 43-61, 1988
2. ARENDT J, HAMPTON S, ENGLISH J, KWASKOWSKI P, MARKS V: 24-hour profiles of melatonin, Cortisol, insulin, C-peptide and GIP following a meal and subsequent fasting. Clin Endocrinol 16, 89-95, 1982
3. ARENDT J, PAUNIER L, SIZENKO PC: Melatonin radioimmunoassay. J Clin Endocrinol Metab 40, 347-350, 1975
4. BARANOWSKA B: Neuroendocrine disturbances in obesity (in Polish). Pol Tyg Lek Suppl 1, 26-28, 1995
5. BARON AD, BRECHTEL G, JOHNSON A, FINDENBERG N, HENRY DP, STEINBERG H: Interactions between insulin and norepinephrine and blood pressure and insulin sensitivity: Studies in lean and obese men. J Clin Invest 93, 2453-2462, 1994
6. BEITINS IZ, BARKAN A, KLIBANSKI A: Hormonal responses to short-term fasting in postmenopausal women. J Clin Endocrinol Metab 60, 1120-1126, 1985
7. BERGA SL, MORTALA JF, YEN SCC: Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 66, 242-247, 1988
8. BIALKOWSKA M, SZOSTAK WB: Selection of obesity treatment as related to the degree of health impairment (in Polish). Pol Tyg Lek Suppl 1, 48-50, 1995
9. BIALKOWSKA M, SZOSTAK WB, CYBULSKA B: Obesity. Definition and diagnostic criteria (in Polish). In: Metabolic Civilization Diseases (in Polish). CMKP, Warszawa (Eds. WB Szostak, B Cybulska), pp. 211-271, 1990
10. BJORNTORP P: Abdominal obesity and the metabolic syndrome. Ann Med 24, 465-468, 1992
11. BOYCE P, KENNAWAY DJ: Effects of light on melatonin production. Biol Psych 22, 473-478, 1987
12. BRAMBILLA F, FRASCHINI F, ESPOSTI G, FERRARI E: Melatonin circadian rhythm in anorexia nervosa and obesity. Psych Res 23, 267-276, 1988
13. BRAY GA, GALLAGHER TF: Manifestations of hypothalamic obesity in men: A comprehensive investigations of 8 patients and a review of the literature. Medicine 54, 301-350, 1975
14. BROWN GM: Light, melatonin and the sleep-wake cycle. J Psych Neurosci 19, 345-353, 1994
15. BRZEZINSKI A, LYNCH HJ, SEIBEL MM, DENG MH, NADER TM, WURTMAN RJ: The circadian rhythm of plasma melatonin during the normal menstrual cycle and in amenorrheic women. J Clin Endocrinol Metab 66, 891-895, 1988
16. CARR DB, REPPERT SM, BULLEN B, SKRINAR G, BEITINS IZ, ARNOLD M, ROSENBLATT M, MARLIN JB, ARTUR JW: Plasma melatonin increases during exercise in women. J Clin Endocrinol Metab 53, 224-225, 1981
17. DEL-RIO G, CARINI G, BONATI M, MARRAMA P, DELLA-CASA L: Sexual dimorphism of the autonomic nervous system response to weight loss in obese patients. Int J Obes Relat Metab Disord 16, 897-903, 1992
18. DEL-RIO G, VELARDO A, Zizzo G, GALETTI S, MARRAMA P, DELLA-CASA L: Daily variations in catecholamine excretion are not influenced by very low diet. J Endocrinol Invest 16, 527-532, 1993
19. DEPRES JP: Regional distribution of body fat, plasma lipoproteins and cardiovascular disease. Atherosclerosis 10, 497-511, 1990
20. DETTAVEN J, SHERVIN R, HENDLER R: Nitrogen and sodium balance and sympathetic nervous system activity in obese subjects treated with low-caloric protein or mixed diet. N Engl J Med 302, 477-482, 1980
21. DITSCHUNEIT HH, FLECHTNER-MORS M, DOLDERER M, FULDA U: Endocrine and metabolic effects of dexfenfluramine in patients with android obesity. Horm Metab Res 25, 573-578, 1993
22. EBADI M, GOVITRAPONG P: Neural pathways and neurotransmitters affecting melatonin synthesis. J Neural Transm 21 (suppl.), 125-155, 1986
23. FERRARI E, FOPPA S, BOSSOLO PA, COMIS S, ESPOSTI G, LICINI V, FRASCHINI F, BRAMBILLA F: Melatonin and pituitary-gonadal function in disorders of eating behaviour. J Pineal Res 7, 115-124, 1989
24. FERRARI E, FRASHINI F, BRAMDILLA F: Hormonal rhythms in eating disorders. Biol Psych 27, 1007-1020, 1990
25. GENAZZANI AR, FACCHINETTI F, PETRAGLIA F, PINTOR C, CORDA R: Hyperendorphemia in obese children and adolescents. J Clin Endocrinol Metab 62, 36-41, 1986.
26. GETTO CJ, FULLERTON DT, CARLSON JH: Plasma immunoreactive beta-endorphin response to glucose ingestion in human obesity. Appetite 5, 329-333, 1984
27. GIVENS JR, WIEDEMANN E, ANDERSEN RN, KITABCHI AE: β-endorphin and β-lipotropin plasma levels in hirsute women: correlation with body weight. J Clin Endocrinol Metab 50, 975-979, 1980.
28. GLASS AR: Endocrine aspects of obesity. Med Clin North Am 73, 139-160, 1989
29. HALBERG F, TONG Y, JOHNSON EA: Circadian system phase as aspects of temporal morphology: procedure and illustrative examples. In:The Cellular Aspects of Biorhythms. Springer Verlag, Berlin (Ed. H von Mayerbach), pp. 1-12, 1967
30. JUNG RT, SHETTY P, BARRAND M: Role of catecholamines in hypotensive response to dieting. Br Med J 1, 12-13, 1979
31. KARASEK M: Melatonin in man (in Polish). Endokrynol Pol 35, 315-322, 1984
32. KENNAWAY DJ, FRITH RG, PHILLIPOU G, MATTHEUS CD, SZAMARK RF: A specific radioimmunoassay for melatonin in biological tissue and fluids and its validation by gas chromatograph-mass spectrometry. Endocrinology 101, 119-127, 1977
33. KLEIN DC, AUERUACH DA, NOMBOODIRH M A, WHEELER GH: Indole metabolism in the mammalian pineal gland. In: The Pineal Gland, vol. I, Anatomy and Biochemistry. CRC Press Inc, Boca Raton, USA (Ed. RJ Reiter), pp. 199-200, 1981
34. LEWY AJ: Biochemistry and regulation of mammalian production. In: The pineal gland. Elsevier (Ed. R Relkin), pp 77 1983
35. Lissoni P, Esposti D, Esposti G: A clinical study on the relationship between the pineal gland and the opioid system. J Neural Transm 65, 63-73, 1986
36. MAXWELL MH, HEBER D, WAKS AU, TUCK M: Role of insulin and norepinephrine in the hypertension of obesity. Am J Hypertens 7, 402-408, 1994
37. MRRLINO G, SCAGLIONE R, PATERNA S, CORRAO S, PARRINELLO G, LICATA A, AMICO C, GANQUZZA A, LICATA G: Lymphocyte β-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function. Eur Heart J 15, 786-792, 1994
38. OSTROWSKA Z, BUNTNER B, MAREK B, ZWIRSKA-KORCZALA K: Association of the pituitary-testicular axis function and sex hormone-binding globulin with melatonin secretion in morbidly obese men. Bull Pol Ac Biol 43, 33-44, 1995a
39. OSTROWSKA Z, BUNTNER B, ZWIRSKA-KORCZALA K, PARDELA M, MAREK B, DROZDZ M: Association between pituitary-ovarian axis function and melatonin secretion during day/night cycle in morbidly obese women with upper body obesity and menstrual disturbances before and after jejunoileostomy. Bull Pol Ac Biol 43, 1995b (in press)
40. OSTROWSKA Z, BUNTNER B, ZWIRSKA-KORCZALA K, SWIETOCHOWSKA E, SPYRA. Z: Circadian variations of norepinephrine and melatonin in extremely obese men and women. Endocrine Regul 30, 19-27, 1996
41. OSTROWSKA Z, SWIETOCHOWSKA E., SPYRA Z, ZWIRSKA-KORCZALA K, BUNTNER B: Comparison of serum melatonin levels in women with extreme obesity before and after 4 to 6 years period after jejunoileostomy (in Polish). Diagn Lab 31, (suppl.) 156, 1995c
42. REIITER RJ: Neuroendocrinology of melatonin. In: Melatonin - Clinical Oxford University Press, Oxford. Perspectives. (Ed. A Miles, DRS Philbrick, C Thompson), pp. 1-42, 1988
43. REITER RJ: The pineal gland. In: Principles and Practice of Endocrinology and Metabolism, pp. 104-109, Lippincott, Philadelphia (Ed. KL Becker), 1990
44. REITER RJ: Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Rev 12, 151-180, 1991
45. ROJDMARK S, BERG A, ROSSNER S, WETTENBERG L: Nocturnal melatonin secretion in thyroid disease and in obesity. Clin Endocrinol (Oxf) 35, 61-65, 1991
46. ROJDMARK S, ROSSNER S, WETTENBERG L: Effect of short-term fasting on nocturnal melatonin secretion in obesity. Metabolism 41, 1106-1109, 1992
47. ROJDMARK S, WETTENBERG L: Short-term fasting inhibits the nocturnal melatonin secretion in healthy men. Clin Endocrinol 30, 451-457, 1989
48. RYWIK S, WEGROWSKA H, PIOTROWSKI W, BRODA G: Epidemiology of obesity as risk factor (in Polish). Pol Tyg Lek Suppl 1, 63-67, 1995
49. SCHWARTZ RS, HALDUR J, BIERMAN EL: The relation of abnormal dietary induced thermogenesis in obesity to plasma triiodothyronine and norepinephrine. Clin Res (Abstracts) 28, 405 A, 1980
50. SLOWINSKA-KLENCKA D, LEWINSKI A: The role of melatonin in human physiology I (in Polish). Post Hig Med. Dosw 47, 209-220, 1993
51. SLOWINSKA-SRZEDNICKA J, ZGLICZYNSKI S., SOSZYNSKI P, WIERZBICKI M, JESKE W: The possible role of β-endorphin in pathogenesis of obesity and essential hypertension. Clin Exp Hyper Theory and Practice 10, 135-139, 1988
52. TATON J. On the pathogenesis of obesity (in Polish). Pol Tyg Lek Suppl 1, 3-10, 1995
53. VAKKURI O: Diurnal rhythm of melatonin in human saliva. Acta Physiol Scand 124, 409-412, 1985
54. WARD KD, SPARROW D, LANDSBFRG L, YOUNG JB, VOKONAS PS, WEISS ST: The relationship of epinephrine excretion to serum lipid levels: The Normative Aging Study. Metabolism 43, 509-513, 1994
55. WETTENBERG L, APERIA B, BECK-FRIIS J, KJELLMAN B.F, LJUNGGREN JG, NILSONE A, PETTERSON U, THAM A, UNDEN F: The relationship between cortisol and melatonin serum levels in patients with affective disorders and in healthy subjects. In: Chronobiology, pp. 183-184, Karger-Basel, Munchen (Ed. EHF Hugh, S Kabat), 1982-1983
56. WHO DOCUMENT: Measuring obesity-classification and description of anthropometric data. Copenhagen; WHO Regional Office for Europe. Nutrition Unit. EVR/ICP/NUT/ 1988, pp. 125